Physician profile
Mohammad D Lateef
NPI 1962445668
$280.00
in general payments reported to CMS, 2019-2025
7 companies · $45.88 in 2025
The $45.88 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2.51 · 2021: $46.91 · 2022: $20.34 · 2023: $49.60 · 2024: $115 · 2025: $45.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.92 | 2021-2024 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $68.54 | 2024-2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $51.10 | 2023-2024 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $20.34 | 2022 | |
| Indivior INC. | $14.70 | 2023 | Perseris |
| Alkermes, INC. | $12.89 | 2023 | Aristada, Lybalvi |
| Validus Pharmaceuticals LLC | $2.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Lateef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.